CAR T-cell Therapy by Mayo Clinic-Trained Hematologist at JCI CenterHow it works
How Much Does CAR T-cell therapy Cost in Turkey in AUD?
CAR T-cell therapy in Turkey typically costs from AUD $222,500 to AUD $326,400. Prices depend on the specific treatment protocol, clinic tier, and the length of hospitalisation required. These costs generally include cell collection, genetic engineering, and long-term monitoring.
- Hospital stay: Usually accounts for 15-20% of the total package for intensive monitoring.
- Specialised diagnostics: Includes PET/CT scans and cardiac mapping frequently required before infusion.
- Genetic engineering: The laboratory-intensive process of modifying T-cells represents the primary cost driver.
- Post-treatment care: Intensive 24-hour nursing and specialist consultations are typically bundled into fixed-price packages.
Bookimed Expert Insight: Paying for a higher-tier package is often a strategic choice for Australians. Medical Park Bahcelievler Hospital offers packages around A$420,000 that include full-board and extensive specialist consultations. This provides significant value compared to basic options. Centres like Istanbul Florence Nightingale Hospital are JCI-accredited and use Mayo Clinic-trained hematologists. This level of expertise matches Australian private standards while remaining far more accessible.
| Turkey | Thailand | |
|---|---|---|
| CAR T-cell therapy | from AUD $222,500 | ≈ AUD $222,500 |
| CAR-T for Pediatric ALL | ≈ AUD $207,700 | from AUD $8,800 |
| CAR-T for Multiple Myeloma | ≈ AUD $207,700 | from AUD $8,800 |
| CAR-T for DLBCL | ≈ AUD $207,700 | from AUD $8,800 |
CAR T-cell therapy Packages in Turkey — November 2026 (AUD Pricing for Australians)
CAR T-cell Therapy by Mayo Clinic-Trained Hematologist at JCI Center
CAR T-cell Therapy by SIOP & EBMT-Certified Hematologist — Full PackageBest CAR T-cell therapy Clinics in Turkey for Australians: 6 Verified Options and AUD Prices
Hisar Hospital Intercontinental
Sebnem Izmir Guner







CAR T-cell therapy Overview in Turkey
- CAR T-cell therapy - from AUD $222,536This therapy modifies patient"s cells to combat cancer, merging immunology and genetics. It"s precise, powerful, potentially one-off treatment.
- Bookimed deposit: $200 or €200.
- Clinic deposit: Pay a set percentage in advance.
Our Trusted Doctors for Australian Patients
View all Doctors
Zafer Gulbas
Dr. Zafer Gulbas founded and directs Turkey’s largest Bone Marrow Transplant Center at Anadolu Medical Center. He is a hematologist-oncologist specializing in complex blood cancers and clotting disorders. Dr. Gulbas trained at top global institutions, including MD Anderson and Fred Hutchinson in the USA. He performs autologous and allogeneic transplants for leukemia, lymphoma, and aplastic anemia.
- Achieved an 81% success rate for autologous bone marrow transplants.
- Supervised over 3,000 successful transplant procedures since 2010.
- Authored over 260 scientific publications with 5,000+ citations in hematology.
- Member of the European Hematology Association and American Hematology Association.

Omur Gokmen Sevindik
Dr. Omur Gokmen Sevindik is a hematologist at Istanbul Florence Nightingale Hospital. He completed a fellowship at the Mayo Clinic, a top-ranked medical center in the US. Dr. Sevindik specializes in treating blood cancers like leukemia and lymphoma. He works at a JCI-accredited facility that treats 300,000 patients annually.
- Performs allogeneic and haploidentical stem cell transplantations.
- Authored 18 articles in international peer-reviewed journals.
- Presented research findings at over 25 international scientific conferences.
- Treats complex conditions including myeloma, aplastic anemia, and thrombocytopenia.

Bulent Eser
Professor Bulent Eser specializes in hematology with a focus on cutting-edge treatments like CAR T-cell therapy at Medical Park Antalya Hospital Complex.
- Over 36 years of experience in hematology and internal medicine
- Member of the European Group for Blood and Marrow Transplantation
- Professor at Erciyes University, Faculty of Medicine
- Active in clinical research and advanced hematologic treatments

Ceyhun Bozkurt
Professor Bozkurt trained in pediatric oncology at top US and Turkish hospitals, with extensive experience in stem cell therapy. As Clinical Director of Pediatric Hematology-Oncology at Medical Park Bahcelievler, he leads one of Turkey's top units.
- Expert in pediatric bone marrow transplantation and CAR T-cell therapies
- Specialized training at Cincinnati Children's Hospital and Harvard's Dana-Farber Cancer Institute
- Published 40+ research papers on childhood cancers and stem cell therapies
- Vice Director of the Stem Cell Transplant Unit at Medical Park
- Active member of EBMT and SIOP – key groups advancing cellular therapies
Reviews about Bookimed: Discover Patients' Insights
All reviews








Share this content
Video Stories from Bookimed Patients
Anna Leonova
FAQ about CAR T-cell therapy in Turkey
What are the risks and side effects of CAR T-cell therapy in Turkey?
CAR T-cell therapy in Turkey carries risks like cytokine release syndrome (CRS), neurotoxicity, and low blood counts. Patients need intensive hospital monitoring for up to 28 days in centres such as Istanbul Florence Nightingale Hospital. Side effects generally reverse with prompt treatment using steroids or anti-IL-6 drugs.
- Cytokine release syndrome: Causes high fever, nausea, and can lead to organ failure.
- Neurotoxicity (ICANS): Symptoms include confusion, slurred speech, and severe headaches.
- Low blood counts: Leads to fatigue, infections, and bleeding; may last months.
- Infections risk: Immune suppression heightens vulnerability to bacterial and fungal infections.
- Hospital stay: Typically 28 days with daily monitoring to catch early side effects.
Bookimed Expert Insight: Turkey’s leading hospitals offer long hospital stays for CAR T-cell therapy, which is vital for managing serious side effects like CRS and neurotoxicity. Clinics like Istanbul Florence Nightingale provide 24/7 nurse care and VIP transfer services, ensuring smooth monitoring and fast intervention. Watch for clinics promising quick cures or luxury perks without this rigourous care.
Patient Consensus: Patients note neurotoxicity symptoms like confusion appear 3-5 days after treatment. Turkish centres are praised for thorough hospital monitoring and supporting recovery over weeks. Australian patients are advised to verify hospital credentials carefully and expect serious hospital care rather than luxury add-ons.
Which cancers can be treated with CAR T-cell therapy in Turkey?
CAR T-cell therapy in Turkey treats blood cancers like Diffuse Large B-cell Lymphoma (DLBCL), B-cell Acute Lymphoblastic Leukaemia (B-ALL), and Multiple Myeloma. Leading centres in Istanbul offer personalised immunotherapy using genetically modified T cells for patients with relapsed or resistant cancers.
- Treated cancers: DLBCL, B-ALL in children and young adults, Multiple Myeloma.
- Hospitals: Istanbul Florence Nightingale and Medical Park Bahcelievler Hospital.
- Therapy method: Autologous T-cell collection, modification, and inpatient infusion.
- Hospital stay: Typically 28 days for therapy and close monitoring.
- Expert care: Treatment led by haematologists certified by Mayo Clinic, SIOP, and EBMT.
Bookimed Expert Insight: Turkey’s top CAR T-cell centres focus on advanced blood cancers with long inpatient stays. Packages often include full diagnostics, transfers, and careful monitoring, which is key for safety. Australian patients benefit from clinics actively serving them with comprehensive care and internationally certified specialists in Istanbul.
Patient Consensus: Patients note that Turkey offers similar CAR T-cell treatments as other countries but advise confirming therapy specifics directly with hospitals. Australians value full package services and expert care, making Turkey a practical option for this complex therapy.
How does the CAR T-cell therapy process work in Turkey?
CAR T-cell therapy in Turkey is a specialised immunotherapy where a patient’s T-cells are collected, genetically altered to target cancer, multiplied in the lab, and infused back. Treatment includes a 28-day hospital stay and strict follow-up for up to two years in top JCI-accredited hospitals.
- T-cell extraction: Collected via leukapheresis in a one-day procedure.
- Genetic modification: T-cells reprogrammed to recognise cancer cells.
- Lab multiplication: Modified cells multiplied over several weeks.
- Infusion: CAR T-cells returned by quick intravenous transfusion.
- Follow-up: Weekly to monthly monitoring for side effects like cytokine release syndrome.
Bookimed Expert Insight: Turkey’s leading clinics, such as Istanbul Florence Nightingale and Medical Park Bahcelievler Hospitals, include a 28-day hospital stay in packages. VIP transfers and 24/7 nurse services add comfort. Patients should consider that follow-up care may last two years, which can impact travel plans. Clinics with JCI and ISO certifications maintain care quality, while verifying payment methods safeguards accountability.
Patient Consensus: Patients say the treatment process is complex but supported by expert teams in Turkey. Strict monitoring after infusion provides peace of mind. Australian patients highlight the importance of clear follow-up arrangements before travel. Transfers and hospital care ease logistics during treatment.
Where can I get CAR T-cell therapy in Turkey?
CAR T-cell therapy is available in Turkey, mainly in Istanbul’s specialised haematology-oncology hospitals such as Istanbul Florence Nightingale and Medical Park Bahcelievler. These centres offer cell treatments and up to 28 days hospital stays in JCI-accredited facilities with expert haematologists like Dr Omur Gokmen Sevindik and Dr Ceyhun Bozkurt.
- Leading hospitals: Istanbul Florence Nightingale Hospital and Medical Park Bahcelievler Hospital offer CAR T-cell therapy.
- Certified doctors: Specialists include Mayo Clinic and SIOP & EBMT-certified haematologists.
- Hospital stays: Packages typically include 28 days in hospital for treatment and monitoring.
- Advanced care: Facilities hold Joint Commission International (JCI) accreditation for patient safety.
- Therapies offered: Cellular immunotherapy, bone marrow transplantation, and stem cell therapy are available.
Bookimed Expert Insight: Many Australians choose Turkey for initial disease control in CAR T therapy due to visa issues elsewhere. Clinics in Istanbul offer full in-hospital care, but patients often continue definitive CAR T-cell infusion in China, the US, or Europe where approved drugs are available. This multi-step journey is common and worth planning upfront.
Patient Consensus: Australians report Turkey provides effective early treatment and specialist attention. Many secure disease control here before travelling abroad for final CAR T-cell infusion. The hospitals deliver thorough monitoring and support throughout the hospital stay.
Is Turkey suitable for international patients seeking CAR T-cell therapy?
Turkey offers CAR T-cell therapy at top JCI-accredited hospitals with expert haematologists and advanced care. Packages include 28-day hospital stays, specialist consultations, and intensive monitoring, making it a cost-effective choice with recognised international standards.
- Clinical expertise: Mayo Clinic-trained and SIOP/EBMT-certified haematologists available.
- Facility accreditation: Istanbul Florence Nightingale Hospital holds JCI and ISO certifications.
- Treatment inclusions: Packages cover hospital stay, blood tests, imaging, and round-the-clock nursing.
- International reach: Facilities serve patients from Australia, USA, Europe, and Commonwealth countries.
- Additional options: Standard immunotherapy and stem cell transplantation also offered.
Bookimed Expert Insight: Many Turkish packages include 28 days of hospital care but no hotel accommodation. Clinics like Istanbul Florence Nightingale provide VIP transfers with premium vehicles, easing patient logistics. Experienced doctors often combine cellular immunotherapy with established haematology care for flexible treatment.
Patient Consensus: Australians appreciate Turkey's cost-effective CAR T-cell therapy. Patients often start with disease control in Turkey before more specialised treatment elsewhere. Quick hospital admission and well-organised care reduce treatment stress.
Are there clinical trials for CAR T-cell therapy in Turkey?
Turkey currently has no registered clinical trials for CAR T-cell therapy for international patients. Research focuses on developing local treatments and academic trials, but certified CAR T therapies with strict hospital monitoring remain limited in availability.
- Clinical trial example: ISIKOK-19 study at Acıbadem Altunizade Hospital.
- Local production efforts by Koç Healthcare and Caring Cross aim to lower costs.
- Specialised hospitals offer CAR T therapy for blood cancers requiring 28-day stays.
- Serious side effects like cytokine release syndrome require close monitoring.
- Turkey ranks first worldwide in clinics offering CAR T therapy (393 clinics).
Bookimed Expert Insight: Despite no official CAR T clinical trials open to foreigners, Turkey leads with 393 clinics providing advanced CAR T therapies. Clinics like Istanbul Florence Nightingale and Medical Park Bahcelievler have JCI accreditation and offer all-inclusive treatment packages with long hospital stays and experienced haematologists.
Patient Consensus: Patients note Turkey mainly offers stem cell therapies, not verified CAR T trials. Many suggest prioritising safety and considering centres in the US or China for certified CAR T treatments.














